2012 - In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi (original) (raw)
In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi
Wagner Alves DE Souza Júdice
PLoS ONE
View PDFchevron_right
1 In vitro and in vivo evaluation of anti-leishmanial and.pdf
Radheshyam Maurya
View PDFchevron_right
preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?
Rodrigo Luiz O. R. Cunha
Environmental Toxicology and Pharmacology, 2020
View PDFchevron_right
Applied Life Science Synthetic and Natural Products Against Leishmaniasis: A Review
Praful Chaudhari
2012
View PDFchevron_right
Furazolidone is a selective in vitro candidate against Leishmania ( L. ) chagasi : an ultrastructural study
gustavo giron
Parasitology Research, 2010
View PDFchevron_right
In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones
Yannick Estevez
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
A Novel Organotellurium Compound (RT01) as a New Antileishmanial Agent
Camila Lima
Korean Journal of Parasitology - KOREAN J PARASITOL, 2009
View PDFchevron_right
Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice
Rosane Silva
International Journal of Antimicrobial Agents, 2012
View PDFchevron_right
In Vivo Antileishmanial Efficacy of Miltefosine Against Leishmania ( Leishmania ) amazonensis
María Fernanda García Bustos
Journal of Parasitology, 2014
View PDFchevron_right
Leishmaniasis treatment—a challenge that remains: a review
Carla Rangel
Parasitology Research, 2008
View PDFchevron_right
Novel Compounds Active against Leishmania major
C. Selitrennikoff
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology
Naouel Eddaikra
BioMed research international, 2016
View PDFchevron_right
In Vivo Therapeutic Effects of Four Synthesized Antileishmanial Nanodrugs in the Treatment of Leishmaniasis
Ali Khamesipour
Iranian Journal of Clinical Infectious Diseases, 2018
View PDFchevron_right
Vitamins (A) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs
Ramesh Kandimalla
Scientific Reports
View PDFchevron_right
Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages
Fabrizio Vitale
Experimental parasitology, 2018
View PDFchevron_right
Chemotherapy of Leishmaniasis: Past, Present and Future
Jyotsna Mishra, Anubha Saxena, Dr Sarman Singh
Current Medicinal Chemistry, 2007
View PDFchevron_right
Activity of the Novel Immunomodulatory Compound Tucaresol against Experimental Visceral Leishmaniasis
John Rhodes
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Treatment of Experimental Leishmaniasis with the Immunomodulators Imiquimod and S‐28463: Efficacy and Mode of Action
S. Buates
The Journal of Infectious Diseases, 1999
View PDFchevron_right
Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania ( Leishmania) amazonensis
Marcio Gomes
Veterinary Parasitology, 2006
View PDFchevron_right
Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum
Antonieta Rojas de Arias
Parasitology International, 2015
View PDFchevron_right
Targeting of Parasite‐Specific Immunoliposome‐Encapsulated Doxorubicin in the Treatment of Experimental Visceral Leishmaniasis
Dr Labanyamoy Kole
The Journal of Infectious Diseases, 2004
View PDFchevron_right
Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007)
Eduardo Gomez
The American journal of tropical medicine and hygiene, 2002
View PDFchevron_right
Enhancement in therapeutic efficacy of miltefosine in combination with synthetic Bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis
Preeti Vishwakarma
Experimental Parasitology, 2012
View PDFchevron_right
The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade
Whelton Miller
2021
View PDFchevron_right
Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum
Renato L T Parreira
Frontiers in Veterinary Science
View PDFchevron_right
Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions
serina Giorgio
2008
View PDFchevron_right